A French-American team reports that Carba1 prevents chemotherapy-induced neuropathy in preclinical models while preserving ...

The chemotherapy-induced peripheral neuropathy market is emerging as a high-value market opportunity driven by the lack of approved therapies and the significant unmet clinical need. Rising global ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why ...